ArchPoint Investors - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 238 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.95 and the average weighting 0.2%.

Quarter-by-quarter ownership
ArchPoint Investors ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2019$377,000
-89.8%
5,000
-79.4%
0.13%
-89.0%
Q2 2019$3,682,000
+42.1%
24,234
+11.5%
1.16%
+50.3%
Q1 2019$2,591,000
+2747.3%
21,734
+986.7%
0.78%
+2572.4%
Q3 2017$91,0002,0000.03%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
Ikarian Capital, LLC 399,400$35,962,0005.36%
Avoro Capital Advisors LLC 3,125,000$281,406,0004.79%
Varenne Capital Partners 324,661$29,236,0004.34%
Evolutionary Tree Capital Management, LLC 96,695$8,707,0004.18%
Ally Bridge Group (NY) LLC 120,000$10,806,0003.78%
Casdin Capital, LLC 1,350,000$121,568,0003.43%
Ghost Tree Capital, LLC 100,000$9,005,0003.23%
GREAT POINT PARTNERS LLC 145,405$13,094,0002.91%
Camber Capital Management LP 825,000$74,291,0002.55%
Alpha DNA Investment Management LLC 17,522$1,577,0001.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders